Previous 1 2 3 4 Next
Illumina to Host Conference Call on July 18 Following Release of Second Quarter 2006 Results
SAN DIEGO, Calif.----July 11, 2006--Illumina, Inc. announced today that it will issue results for the second quarter and first six months of fiscal year 2006 following the close of the market on Tuesday, July 18, 2006. (Tue, 11 Jul 2006 10:00:00 GMT)
DNAPrint Genomics Announces Ancestry e-Symposium
DNAPrint Genomics, Inc. today announced a free worldwide electronic Ancestry e-Symposium that will enable those interested in determining their family heritage to participate in on- line discussions with world-class experts in the field. (Tue, 11 Jul 2006 11:00:00 GMT)
Applied Biosystems Completes Acquisition of Agencourt Personal Genomics, Developer of Genetic Analysis Technologies
FOSTER CITY, Calif.----July 11, 2006--Applied Biosystems Group , an Applera Corporation business, today announced that it has completed its previously announced acquisition of Agencourt Personal Genomics , a privately-held developer of next-generation genetic analysis technologies, for approximately $120 million in cash. (Tue, 11 Jul 2006 11:00:00 GMT)
Applied Biosystems Joins the Genographic Project to Support Landmark Population Genetics Study Mapping the History of
Applied Biosystems ( Nachrichten ) (NYSE:ABI), an Applera Corporation business, and the Genographic Project today announced that Applied Biosystems has joined the Genographic Project as a supporting sponsor. (Tue, 11 Jul 2006 11:26:44 GMT)
Heart drug riddle solved
Beta blockers' ability to combat chronic failure linked to genetics Researchers at the University of Maryland School of Medicine say they have solved a mystery that has intrigued cardiologists for years: why one of the most commonly prescribed heart medications doesn't always work. (Tue, 11 Jul 2006 11:27:11 GMT)
Applied Biosystems Closes Agencourt Buy
Applied Biosystems Group, a unit of Applera Corp. that makes data-managing life science systems, said Tuesday it completed the acquisition of Agencourt Personal Genomics, a developer of genetic analysis technologies, for about $120 million in cash. (Tue, 11 Jul 2006 11:41:16 GMT)
Applied Biosystems Closes Agencourt Buy
(AP) FOSTER CITY, Calif. Applied Biosystems Group, a unit of Applera Corp. that makes data-managing life science systems, said Tuesday it completed the acquisition of Agencourt Personal Genomics, a developer of genetic analysis technologies, for about $120 million in cash. (Tue, 11 Jul 2006 11:50:13 GMT)
Reproductive Medicine Associates of New Jersey Enters Multi Year Agreement With GeneGo to Access MetaCore
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that Reproductive Medicine Associates of New Jersey have licensed MetaCore to use for research and in their clinic. (Tue, 11 Jul 2006 12:00:00 GMT)
Med BioGene Inc.'s Chief Scientific Officer to present at prestigous P.O.E.T.I.C. Conference to be held July 19-21 in
Med BioGene Inc. is pleased to announce that its Chief Scientific Officer, Dr. Nathan Yoganathan, will be presenting at the Pediatric Oncology Experimental Therapeutics Investigation Consortium, or P.O.E.T.I.C., Conference being held July 19-21 in Banff, Alberta. (Tue, 11 Jul 2006 12:30:00 GMT)
Ciphergen Reports Discovery of Novel Biomarkers Linked to Pre-Eclampsia
Ciphergen Biosystems, Inc. announced the discovery of a panel of biomarkers present in urine that could distinguish pregnant women with pre-eclampsia from healthy pregnant women. The results were presented at the 15th World Congress of International Society for the Study of Hypertension in Pregnancy in Lisbon, Portugal, July 2nd -5th. (Tue, 11 Jul 2006 13:00:00 GMT)
Agreement to increase the flow of ideas from laboratory to clinic
The University of Manchester and pharmaceutical company AstraZeneca have signed an agreement to enhance each organisation's research into diseases such as cancer, inflammatory diseases and diabetes and obesity. (Tue, 11 Jul 2006 13:09:20 GMT)
View Global Pharmacogenomics Market in Million $ - Bioinformatics Market Update (2006)
DUBLIN, Ireland----July 11, 2006--Research and Markets has announced the addition of "Bioinformatics Market Update " to their offering. (Tue, 11 Jul 2006 13:52:00 GMT)
Does My Diet Fit My Genes?
The new science of nutrigenomics has some answers. It explains why fat and caffeine are worse for some than others (Tue, 11 Jul 2006 14:19:22 GMT)
DNAPrint Genomics Announces Ancestry e-Symposium
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced a free worldwide electronic Ancestry e-Symposium that will enablethose interested in determining their family heritage to participate in on-line discussions with world-class experts in the field. (Tue, 11 Jul 2006 15:11:54 GMT)
Science and security in the 21st century
Over the decades, physicists and chemists have got used to the concept of dual-use research and its implications-that knowledge, technologies and materials, which could be used to construct weapons of mass destructions, are tightly regulated for security purposes. (Tue, 11 Jul 2006 15:23:50 GMT)
Ciphergen Reports Discovery of Novel Biomarkers Linked to Pre-Eclampsia
FREMONT, Calif., July 11 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. announced the discovery of a panel of biomarkers present in urine that could distinguish pregnant women with pre-eclampsia from healthy pregnant women. (Tue, 11 Jul 2006 16:09:27 GMT)
DNAPrint Genomics Announces Ancestry E-Symposium
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced a free worldwide electronic Ancestry e-Symposium that will enable those interested in determining their family heritage to participate in on- line discussions with world-class experts in the field. (Tue, 11 Jul 2006 16:11:48 GMT)
Syska Hennessy Group Acquires Caretsky & Associates, Establishing an Office in Texas
HOUSTON----July 11, 2006--As part of a strategic plan to strengthen its presence in Texas, Syska Hennessy Group has acquired Caretsky & Associates Consulting Engineers. Caretsky's Houston operations are now a regional office of Syska Hennessy Group, Inc., serving healthcare, critical facilities, research labs, and higher education markets. (Tue, 11 Jul 2006 17:31:00 GMT)
DOE Publishes Research Roadmap For Developing Cleaner Fuels
The report outlines a detailed research plan for developing new technologies to transform cellulosic ethanol--a renewable, cleaner-burning, and carbon-neutral alternative to gasoline--into an economically viable transportation fuel... (Tue, 11 Jul 2006 18:23:04 GMT)
Energy-rich portfolio of new genome sequencing targets for U.S. Department of Energy Joint Genome Institute
Bioenergy crop plants switchgrass and cassava, other important agricultural commodities such as cotton, and microbes geared to break down plant material to render biofuels, round out the roster of more than 40 projects to be tackled by the U.S. Department of Energy Joint Genome Institute (DOE JGI) over the next year. (Tue, 11 Jul 2006 19:15:44 GMT)
Interspecies embryonic stem cell
Present invention demonstrates the derivation of ES cells from hybrid blastocysts, obtained by the mating of two different Mus species. The invention also relates to the use of these interspecies hybrid ES cells for the generation of (Tue, 11 Jul 2006 19:25:34 GMT)
Compositions and methods for treatment of herpes
Prophylactic and treatment methods for treatment of herpes, as well as methods for reducing or preventing the transmission of herpes. The methods comprise the step of administering to a mammal, an amount of a (Tue, 11 Jul 2006 19:25:44 GMT)
The Next Generation in Sequencing Is SOLiD
July 11, 2006 | Applied Biosystems (AB) has completed the acquisition of Massachusetts-based genetic analysis company Agencourt Personal Genomics (APG) for $120 million, and hopes to bring the company’s novel next-generation sequencing technology to market next year. (Tue, 11 Jul 2006 20:15:32 GMT)
Invitrogen and the Human Proteome Organisation Enter Protein Research Scientific Partnership
CARLSBAD, Calif.----July 11, 2006--Invitrogen Corporation and the Human Proteome Organisation have entered a scientific collaboration focused on advancing proteomic research through education initiatives, standardization of research protocols and development of advanced proteomic products. (Tue, 11 Jul 2006 21:00:00 GMT)
News tips from the Journal of Neuroscience
The excitatory amino acid transporter 4 (EAAT4) is an unusual beast. Expressed predominantly in cerebellum Purkinje cells rather than glia, the molecule also functions as an anion-selective ion channel. (Tue, 11 Jul 2006 21:28:32 GMT)
Invitrogen Corporation Global Volunteer Day Advances Environmental Causes; Employees From More Than 25 Sites Clean,
More than 2,000 employees from Invitrogen Corporation's (Nasdaq:IVGN) 25 global offices will head into their communities on Thursday, July 13 to take part in an effort to improve the areas where they live and work in the company's 3rd Annual Global Volunteer Day. (Tue, 11 Jul 2006 22:07:40 GMT)
Ciphergen Reports Discovery Of Novel Biomarkers Linked To Pre-Eclampsia
CiphergenBiosystems, Inc. (Nasdaq: CIPH) announced the discovery of a panel ofbiomarkers present in urine that could distinguish pregnant women withpre-eclampsia from healthy pregnant women. The results were presented atthe 15th World Congress of International Society for the Study ofHypertension in Pregnancy (ISSHP) in Lisbon, Portugal, July 2nd -5th. IrinaA, Buhinschi, M.D. [click link for full (Wed, 12 Jul 2006 07:03:31 GMT)
Mendel Bio enters research collaboration with Monsanto
Mendel Biotechnology, Inc. announced a new research and commercialization partnership with Monsanto Company. (Wed, 12 Jul 2006 09:45:32 GMT)
Applied Biosystems Adds More Than a Million New TaqMan(R) SNP Genotyping Assays to Its Collection
FOSTER CITY, Calif.----July 12, 2006--Applied Biosystems , an Applera Corporation business, today announced it has added more than a million new assays to its collection of pre-designed, ready-to-use TaqMan® SNP Genotyping Assays. (Wed, 12 Jul 2006 11:00:00 GMT)
Applied Biosystems Adds More Than a Million New TaqMan(R) SNP Genotyping Assays to Its Collection
Ready-to-Use Assays Enable Researchers to Easily Conduct Experiments Using the Recently Completed HapMap Dataset and Additional Pharmaceutically Relevant 'Coding SNPS' (Wed, 12 Jul 2006 11:00:00 GMT)
Mitrion Platform Selected by U.S. Naval Research Laboratory for World's Largest FPGA Supercomputer System
Mitrionics(TM), Inc., developer of the Mitrion(TM) Virtual Processor and software-centric Mitrion-C programming language for FPGA Supercomputing acceleration, today announced that the U.S. (Wed, 12 Jul 2006 12:20:00 GMT)
John W. Manzetti Joins the PLSG as an Executive in Residence
The Pittsburgh Life Sciences Greenhouse , the private/public partnership putting the region's life sciences industry on a fast track for growth, today announced it has added John W. (Wed, 12 Jul 2006 14:24:00 GMT)
Flu Vaccines Will Be Faster And Cheaper To Produce, Thanks To MSU Technology
Technology from Michigan State animal science labs looks to produce new human flu vaccines quicker and cheaper than current methods. [click link for full article] (Wed, 12 Jul 2006 17:03:24 GMT)
Twins Study Spots Three Rheumatoid Arthritis Genes
WEDNESDAY, July 12 (HealthDay News) -- A study of identical twins has uncovered three genes that may be associated with rheumatoid arthritis, researchers report. (Wed, 12 Jul 2006 18:02:26 GMT)
Expats Offer Ideas for Developing Biotech Here
By David Robinson, The Buffalo News, N.Y. Jul. 10--Kenmore native Peter Barton Hutt serves on the board of eight biotechnology companies, so he knows very well how those fledgling firms can't afford to waste time as they burn through their cash. (Wed, 12 Jul 2006 18:37:55 GMT)
Beyond GM food
For years, the life science companies — Monsanto, Syngenta, Bayer, Pioneer — have argued that genetically modified (GM) food is the next great scientific and technological revolution in agriculture, and the only efficient and cheap way to feed a growing population in a shrinking world. (Wed, 12 Jul 2006 20:39:00 GMT)
Researchers Discover Communication Signal for Tissue Development
Researchers at Rensselaer Polytechnic Institute have discovered a communication signal between cells that plays an important role in cell adhesion and detachment. The finding provides new information about how cells and tissues determine when to let go from surfaces during new growth, according to the researchers. (Wed, 12 Jul 2006 21:20:31 GMT)
New Source Of Multipotent Adult Stem Cells Discovered In Human Hair Follicles
Researchers at the University of Pennsylvania School of Medicine have isolated a new source of adult stem cells that appear to have the potential to differentiate into several cell types. Their approach could one day provide the tissue needed by an individual for treating a host of disorders, including peripheral nerve disease, Parkinson's disease, and spinal cord injury. (Wed, 12 Jul 2006 22:21:44 GMT)
Grass roots research will help develop new energy crops
The John Innes Centre (JIC) has recently entered into a partnership with the US Dept of Agriculture (USDA) and Department of Energy (DOE) to study the genome of the grass Brachypodium as part of the Joint Genome Institute’s Community Sequencing Programme. (Wed, 12 Jul 2006 23:00:44 GMT)
Donor T Cells Change The Fate Of Stem Cells In Transplantation
When a transplant patient suffers complications such as graft rejection or graft-versus-host disease, physicians attempt to stop the body's immune response by targeting a patient's T cells. In a new study, University of Illinois at Chicago College of Medicine researchers suggest there may be a way to prevent these complications before they occur. The study was published July 1 in the journal (Thu, 13 Jul 2006 04:36:14 GMT)
Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi
LAFAYETTE, Colo.----July 13, 2006--The Genome-Wide RNAi Global Initiative , an alliance of Dharmacon, Inc. and leading international research centers pioneering the use of whole-genome RNAi screening, today announced the addition of new members from Harvard Medical School, Stanford Medical School and the VU University Medical Center in the Netherlands. (Thu, 13 Jul 2006 07:00:00 GMT)
Illumina Announces HumanHap550+ and iSelect Infinium(TM) Genotyping Products
SAN DIEGO----July 13, 2006--Illumina, Inc. announced today the immediate availability of two new Infinium genotyping products that provide an unprecedented degree of customization for customers performing whole-genome and focused-content SNP genotyping. (Thu, 13 Jul 2006 10:00:00 GMT)
CombiMatrix and Furuno Launch DNA Microarray Synthesizer
NEWPORT BEACH, Calif.----July 13, 2006--Acacia Research Corporation announced today that its CombiMatrix group, working in partnership with Furuno Electric Co., Ltd. of Japan, has launched its new QuadroCAS CustomArray Synthesizer. (Thu, 13 Jul 2006 10:00:00 GMT)
Illumina to Conduct Custom Genotyping for Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
SAN DIEGO----July 13, 2006--Illumina, Inc. announced today that it has signed a genotyping services agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. . (Thu, 13 Jul 2006 10:01:00 GMT)
PEOPLE ON THE MOVE
Steve Reinhardt Expresso Fitness of Sunnyvale, a supplier of interactive software for Internet-enabled cardio fitness systems, appointed Steve Reinhardt vice president of marketing. (Thu, 13 Jul 2006 10:17:39 GMT)
Treasures In The Trash
What they used to call junk DNA may reveal the most important medical secrets of all. (Thu, 13 Jul 2006 10:23:16 GMT)
Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon As Members of RNAi
The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc. (Thu, 13 Jul 2006 10:25:05 GMT)
DNAPrint Genomics Ancestry e-Symposium to Feature Gavin Menzies, Noted Historian and Author of Theory That Chinese
DNAPrint Genomics, Inc. today announced that Gavin Menzies, the author of "1421 -- The Year China Discovered the World," will participate in the Ancestry e-Symposium to be held on Wednesday, July 19, beginning at 11:00 AM Eastern time at www.ancestry.e-symposium.com. Mr. (Thu, 13 Jul 2006 11:00:00 GMT)
Biosite(R) Announces FDA Clearance to Market Triage(R) TOX Drug Screen
SAN DIEGO, July 13 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated , a research-based provider of novel, rapid medical diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) clearance to add methadone to its Triage(R) TOX Drug Screen. (Thu, 13 Jul 2006 11:11:31 GMT)
Stellar Pharmaceuticals & Bio-Technic Sign Licensing Agreement for Neovisc'R' in Romania
Stellar Pharmaceuticals Inc.(OTC.BB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced the signing of a Licensing Agreement with BIO-TECHNIC ROMANIA SRL for NeoVisc® in Romania. (Thu, 13 Jul 2006 12:00:00 GMT)
Nanogen Releases New Real-Time PCR Reagents
Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has expanded its product portfolio to include MGB Alert real-time PCR reagents designed to assist laboratories in developing tests that can detect sequences associated with varicella-zoster virus and Bordetella bacteria. (Thu, 13 Jul 2006 12:00:00 GMT)
Allergy Battle Could Be Won In Five Years, Says Scientist
Allergies such as asthma, eczema and hay fever could be snuffed out within five years thanks to pioneering work at The University of Manchester. (Thu, 13 Jul 2006 12:36:35 GMT)
Reversing "hibernating" heart muscle focus of UB research
Heart researchers at UB have received a five-year, $2.5 million grant to develop new strategies to reverse a heart dysfunction called "hibernating myocardium" that can cause disabling heart failure and sudden death. (Thu, 13 Jul 2006 13:43:44 GMT)
State-of-the-art technology being applied to agricultural problems
Armed with the latest high-tech research equipment, Agricultural Research Service (ARS) scientists in Mississippi are investigating the genetic secrets of catfish, cotton, soybeans and other crops. (Thu, 13 Jul 2006 14:30:24 GMT)
Synova Healthcare Enters into Exclusive Distribution Agreement With QuantRx(R) Biomedical Corporation
Synova Healthcare, Inc., a subsidiary of Synova Healthcare Group, Inc. (OTC BB: SNVH), has entered into an exclusive distribution agreement with QuantRx(R) Biomedical Corporation, a medical technology company with products targeting worldwide health needs. (Thu, 13 Jul 2006 15:12:44 GMT)
Nanogen Releases New Real-Time PCR Reagents
SAN DIEGO, July 13 /PRNewswire-FirstCall/ -- Nanogen, Inc. (Thu, 13 Jul 2006 15:13:45 GMT)
Biosite(R) Announces FDA Clearance to Market Triage(R) TOX Drug Screen
SAN DIEGO, July 13 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated , a research-based provider of novel, rapid medical diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) clearance to add methadone to its Triage(R) TOX Drug Screen. (Thu, 13 Jul 2006 15:15:01 GMT)
DNAPrint Genomics Ancestry e-Symposium to Feature Gavin Menzies, Noted Historian and Author of Theory That Chinese
The Year ChinaDiscovered the World,' will participate in the Ancestry e-Symposium to beheld on Wednesday, July 19, beginning at 11:00 AM Eastern time atwww.ancestry.e-symposium.com. Mr. Menzies' book puts forth the theory thatChinese sailors discovered America before Christopher Columbus and alsowere the first to circumnavigate the globe. (Thu, 13 Jul 2006 15:55:20 GMT)
Caretsky acquired by Syska Hennessy Group
Syska Hennessy Group has acquired Caretsky & Associates Consulting Engineers, a firm with roots in the Houston area. (Thu, 13 Jul 2006 18:35:31 GMT)
SDI Provides Update on Independent Evaluations of Its New RapidChek SELECT(TM) Salmonella Test Method
NEWARK, Del.----July 13, 2006--Strategic Diagnostics Inc. , a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today announced that an additional 12 "beta test" evaluations for its new RapidChek SELECT Salmonella product commenced in several large poultry companies and independent (Thu, 13 Jul 2006 18:53:00 GMT)
Applied Biosystems Group and Celera Genomics Group Fourth Quarter and Fiscal 2006 Financial Results and Conference Call
NORWALK, Conn.----July 13, 2006--Applera Corporation announced today that it will issue fiscal 2006 fourth quarter and full year results for its Applied Biosystems Group and Celera Genomics Group on Thursday, July 27, 2006. (Thu, 13 Jul 2006 21:22:00 GMT)
Genomics luminary weighs in on US faith debate
Top geneticist asks the God question. (Thu, 13 Jul 2006 21:32:31 GMT)
Gene Mutations Responsible For Rett Syndrome In Females Present Sporadically In Males
Gene mutations that are responsible for the majority (70 to 80 percent) of cases of Rett syndrome (RTT) in females are not always lethal in males prior to birth, refuting previous assumptions, and can occur sporadically in infant males without a family history of the disorder. A study published in the journal Neurology reports four sporadic occurrences of MECP2 gene mutations in infant males with (Thu, 13 Jul 2006 22:06:14 GMT)
Scientists Build Brain Box Computer
Scientists at The University of Manchester are to build a new type of computer which mimics the complex interactions within the human brain. The aim is to build a computer which mimics how nerve cells in the brain interact in a bid to engineer more 'fault tolerant' electronics. (Thu, 13 Jul 2006 22:06:24 GMT)
CombiMatrix and Furuno Launch DNA Microarray Synthesizer
(July 13, 2006) North America, BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG) (Nasdaq:CBMX) announced today that its CombiMatrix group, working in partnership with Furuno Electric Co., Ltd. of Japan, has launched its new QuadroCAS(TM) CustomArray(TM) Synthesizer. (Thu, 13 Jul 2006 22:38:22 GMT)
MUHS to start M Sc in pharmaceutical medicine with IFAPP curriculum
The University Dept. of Interpathy & Research Technology of the Maharashtra University of Health Sciences (MUHS), in collaboration with Seth G S Medical College & KEM Hospital, Mumbai, is starting a two-year postgraduate degree course in Pharmaceutical Medicine (M Sc Pharma. (Fri, 14 Jul 2006 02:45:42 GMT)
Opportunities For Structured Doctoral Research
With the establishment of 34 new Research Training Groups, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) continues to promote structured doctoral programmes. [click link for full article] (Fri, 14 Jul 2006 05:03:02 GMT)
Twins Study Spots Three Rheumatoid Arthritis Genes
Title: Twins Study Spots Three Rheumatoid Arthritis Genes Category: Health News Created: 7/13/2006 9:36:00 AM Last Editorial Review: 7/13/2006 9:36:02 AM (Fri, 14 Jul 2006 07:18:16 GMT)
Latest genome project aims to unlock biofuel potential
Scientists for the U.S. Agriculture and Energy Departments are teaming up in the Bay Area to divine the genetic recipe for switchgrass and other potential energy crops, for dramatic boosts in the (Fri, 14 Jul 2006 09:56:14 GMT)
Microsoft to Highlight Next-Gen Web 2.0 Work at Upcoming Research Summit
Windows Live Image Search and a new social-bookmarking project are among the agenda items on the Microsoft Research Faculty docket. (Fri, 14 Jul 2006 10:27:32 GMT)
EGFR And Reactive Astrocytes
In this week's Journal, Liu et al. provide some insight on what makes a "reactive" astrocyte reactive. The authors look at activated astrocytes using several models of optic nerve injury. The epidermal growth factor receptor (EGFR) was not expressed by quiescent astrocytes but was upregulated in rat optic nerve astrocytes after ischemia, nerve transection, and in a chronic glaucoma model. [click (Fri, 14 Jul 2006 12:03:06 GMT)
US$3 billion bid to boost biotech in Brazil
[RIO DE JANEIRO] A Brazilian consortium has unveiled a multi-billion-dollar strategy aimed at making the country a world leader in biotechnology. (Fri, 14 Jul 2006 14:48:34 GMT)
BioMachines Announces New Proteomics Services Division
BioMachines Inc., a biotech company that develops, manufactures and sells advanced automation tools to accelerate drug discovery and development, announced today a new services division -- Applied Proteomics Services. (Fri, 14 Jul 2006 16:00:00 GMT)
Life Science Is Music To Ears Of New Charlotte Research Institute Director
Editor’s note: Charlotte Beat is a regular feature in WRAL Local Tech Wire. (Fri, 14 Jul 2006 16:05:03 GMT)
Quitting Smoking Improves Lung Function Considerably
For smokers with asthma, quitting smoking can improve lung function test scores by more than 15 percent in less than two months. (Fri, 14 Jul 2006 16:06:34 GMT)
NASA Excerpt: Senate Report 109-280 Departments of Commerce and Justice, Science and Related Agencies Appropriations
The Committee recommendation provides $16,757,227,000 for the National Aeronautics and Space Administration [NASA]. The recommendation is $510,613,000 above the fiscal year 2006 enacted level, excluding emergency supplemental appropriations, and $35,000,000 below the budget request. (Fri, 14 Jul 2006 16:27:06 GMT)
NASA Excerpt: Senate Report 109-280 Departments of Commerce and Justice, Science and Related Agencies Appropriations
Quelle: Space Wire Top Stories (Fri, 14 Jul 2006 16:45:34 GMT)
University of California Riverside researchers determine genetic origin of California wild radish
UC Riverside scientists studying the genetic makeup of wild radishes in California have determined that the California wild radish is descended from hybrids between two species: cultivated radish and the weed, jointed charlock. (Fri, 14 Jul 2006 18:15:34 GMT)
BioMachines Launches Division For Proteomic Services
RESEARCH TRIANGLE PARK, N.C. – BioMachines, which builds automation tools for use in drug discovery and development, is launching a new division focused on proteomics. (Fri, 14 Jul 2006 19:05:03 GMT)
Health Business
RESEARCH TRIANGLE PARK, N.C., July 14 (UPI) -- BioMachines said Friday it added a new division that will focus on providing services for proteomics research. (Fri, 14 Jul 2006 19:59:30 GMT)
Microsoft to Highlight Next-Gen Web Work at Research Summit
On July 17 and 18, Microsoft researchers, product group engineers and architects and invited academic researchers from around the world will convene in Redmond, Wash., to discuss everything from bioinformatics and e-science to nomadic computing and mesh networking. (Fri, 14 Jul 2006 20:03:39 GMT)
Research Collaboration Between The University Of Manchester And AstraZeneca
The University of Manchester and pharmaceutical company AstraZeneca have signed an agreement to enhance each organisation's research into diseases such as cancer, inflammatory diseases and diabetes and obesity. [click link for full article] (Fri, 14 Jul 2006 22:03:04 GMT)
US$3 billion bid to boost biotech in Brazil
[RIO DE JANEIRO] A Brazilian consortium has unveiled a multi-billion-dollar strategy aimed at making the country a world leader in biotechnology. (Sat, 15 Jul 2006 01:03:45 GMT)
New convention center taking shape
James Jessie is the man in charge of making sure taxpayers' $600 million investment in the Phoenix Convention Center expansion pays off. And he's in a good mood because he got a phone call last week, and it was one of the good ones. (Sat, 15 Jul 2006 06:21:59 GMT)
New Tool Cracks Genomic Code Quicker Than Ever
US and Australian scientists have pioneered a new hybrid method for genomic sequencing that is faster and cheaper than state of the art technologies. The breakthrough will be welcomed in medical and biotechnology circles where there is rising demand for genome-sequencing technologies. The new hybrid method combines the best of new and old code cracking methods for "fingerprinting" the genetic (Sat, 15 Jul 2006 16:06:04 GMT)
Communication Signal For Tissue Development Discovered By Researchers
Researchers at Rensselaer Polytechnic Institute have discovered a communication signal between cells that plays an important role in cell adhesion and detachment. The finding provides new information about how cells and tissues determine when to let go from surfaces during new growth, according to the researchers. [click link for full article] (Sat, 15 Jul 2006 18:02:59 GMT)
City Of Hope Joins The Multiple Myeloma Research Consortium
City of Hope has joined the Multiple Myeloma Research Consortium (MMRC), a collaboration of 11 research institutions nationwide that are working together to accelerate therapies to treat multiple myeloma. [click link for full article] (Sun, 16 Jul 2006 07:03:49 GMT)
Biosite(R) Announces FDA Clearance To Market Triage(R) TOX Drug Screen
Biosite(R) Incorporated(Nasdaq: BSTE), a research-based provider of novel, rapid medicaldiagnostics, today announced it has received U.S. Food and DrugAdministration (FDA) clearance to add methadone to its Triage(R) TOX DrugScreen. [click link for full article] (Sun, 16 Jul 2006 07:05:30 GMT)
Questions trail local entrepreneur
July 16 (UNION-TRIBUNE): For allergic cat lovers, a San Diego company's claim to have produced the world's first kittens that are virtually free of allergy-producing proteins is nothing to sneeze at. (Sun, 16 Jul 2006 13:01:41 GMT)
New Strategy Rapidly Identifies Cancer Targets
In a step toward personalized medicine, Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. (Sun, 16 Jul 2006 16:02:39 GMT)
New strategy rapidly identifies cancer targets
In a step toward personalized medicine, Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. By analyzing the proteins -- instead of the genes -- inside acute myeloid leukemia (AML) cells, the researchers have dramatically reduced the time it takes to zero in (Sun, 16 Jul 2006 16:23:38 GMT)
Key to invasive weeds may be locked in genes, says UBC prof
The lowly sunflower has climbed up the botanical hierarchy thanks to the work of a UBC professor who is unlocking its role in weed control and species evolution. (Sun, 16 Jul 2006 17:32:34 GMT)
Bangalore District JD (S) Youth Wing:
Birthday celebrations of JD (S) President, MP Prakash, Minister for Forests and Environment Chennigappa to be present, Beggars’ Colony, Magadi Road, Sumanahalli, Sunkadakatte Main Road, 12 am. (Sun, 16 Jul 2006 21:17:48 GMT)
UP ITTC gears up for 4th Y4IT
The University of the Philippines Information Technology Training Center (UP ITTC), UP System IT Foundation (UP SITF), and Virtual Center for Technology Innovation in Information Technology (VCTI- IT), in cooperation with the Philippine Society of IT Educators (PSITE), Computing Society of the Philippines (CSP), and VCTI-IT Student Volunteer Corps, present this year’s Philippine Youth Congress (Mon, 17 Jul 2006 01:44:50 GMT)
Eco devo, biotech big winners in legislature
Editor's Note: With the General Assembly session in its final stretch, and the budget a done deal, it's a good time to begin toting up the winners and losers of 2006. For the first time in years, legislators had a surplus - almost $2 billion of extra cash - and they found a way to spend it. Among the biggest beneficiaries were educational institutions, the biotech industry and economic (Mon, 17 Jul 2006 04:32:02 GMT)
Economic development director search begins
Nine months after Jill Nishi left for a job with the Bill & Melinda Gates Foundation, the city of Seattle's influential Office of Economic Development is officially launching its search for a new director. (Mon, 17 Jul 2006 04:32:56 GMT)
New N.C. budget rewards recruitment, biotech and education
With the General Assembly session in its final stretch, it's a good time to begin toting up the winners and losers of 2006. (Mon, 17 Jul 2006 04:35:46 GMT)
UNC's $145M genomics dream
CHAPEL HILL - Leaders of the University of North Carolina at Chapel Hill are placing a $145 million bet on a glitzy new research building they hope will put UNC at the forefront of the genomics revolution. (Mon, 17 Jul 2006 04:49:36 GMT)
Experimental shot shows promise against cancer
Eugene Overton was given two options after being diagnosed with melanoma last year: standard chemotherapy or an experimental treatment. (Mon, 17 Jul 2006 05:37:40 GMT)
Scientists devise simpler strategy to identify cancer targets
Washington: Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. (Mon, 17 Jul 2006 09:50:43 GMT)
DNAPrint Genomics Selects PT-502 Lead Research Compound for Development of Drug for Treating Depression
DNAPrint Genomics, Inc. today announced it has confirmed positive results in an animal model for anti-depressant activity for its PT-502 lead compound being developed with the Massachusetts College of Pharmacy and Health Sciences. (Mon, 17 Jul 2006 11:00:00 GMT)
Celera Discovers Gene Variants Strongly Associated with Alzheimer's Disease
ROCKVILLE, Md.----July 17, 2006--Celera Genomics , an Applera Corporation business, today announced the publication of data from its research studies showing that variants in the death-associated protein kinase 1 gene on human chromosome 9 correlate strongly with risk for late-onset Alzheimer's disease. (Mon, 17 Jul 2006 11:00:00 GMT)
(AFX UK Focus) 2006-07-17 12:33 GMT: Celera discovers gene variants strongly associated with Alzheimer's disease
LONDON (AFX) - Celera Genomics, a unit of Applera Corp, said its research has shown a strong correlation between variants in the DAPK1 gene and the risk of late-onset Alzheimer's disease, which could lead to the development of new treatments for the condition. (Mon, 17 Jul 2006 11:56:28 GMT)
Beckman Coulter Licenses Roche PCR Tech
Beckman Coulter Inc., a maker of medical testing equipment, said Monday it licensed molecular technology from Roche Diagnostics, a unit of Swiss drug maker Roche Holding AG, to complete an intellectual property portfolio needed to develop a certain type of genetic testing. (Mon, 17 Jul 2006 12:28:37 GMT)
Beckman Coulter Licenses Roche PCR Tech
(AP) FULLERTON, Calif. Beckman Coulter Inc., a maker of medical testing equipment, said Monday it licensed molecular technology from Roche Diagnostics, a unit of Swiss drug maker Roche Holding AG, to complete an intellectual property portfolio needed to develop a certain type of genetic testing. (Mon, 17 Jul 2006 12:35:36 GMT)
Power3 Chairman/CEO Steven Rash to Discuss Progress in Early Detection Blood Testing for Breast Cancer and
HOUSTON----July 17, 2006--Steven Rash, chairman and CEO of Power3 Medical Products, Inc. , a leading proteomics company that develops and commercializes early detection diagnostic tests for breast cancer and neurodegenerative diseases, will discuss his company's progress in developing blood-based early detection testing in an online radio interview available worldwide tomorrow . (Mon, 17 Jul 2006 12:51:00 GMT)
QuantRx(R) Biomedical Corporation Selects Synova Healthcare as the Exclusive Distributor of Its PAD Technology -- to Be
QuantRx® Biomedical Corporation announced today that it has entered into an exclusive distribution agreement for its PAD technology with Synova Healthcare, a distributor of diagnostic products. Under this agreement, QuantRx® received an up-front payment of $500,000 and is eligible to receive royalties, based upon sales, estimated to be worth multi-million dollars, over the term of the multi-year (Mon, 17 Jul 2006 14:02:00 GMT)
Scientists isolate leukemia stem cells in a model of human leukemia
Boston -- Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston and their colleagues have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease. (Mon, 17 Jul 2006 14:29:43 GMT)
Rosetta Biosoftware Licenses the Rosetta Resolver Expression Data Analysis System to University of Nebraska-Lincoln
SEATTLE----July 17, 2006--Rosetta Biosoftware announced today that University of Nebraska-Lincoln licensed the Rosetta Resolver® system to study gene regulation networks at the UNL Center for Biotechnology. (Mon, 17 Jul 2006 15:00:00 GMT)
CS-Keys Garners Investment From Triathlon Medical Ventures; Company Continues Its Quest to Slash Breast Cancer
CS-Keys, Inc. (CS-Keys) announced today a significant seed investment in the company by Midwest-based Triathlon Medical Ventures (Triathlon). CS-Keys has developed a new diagnostic tool that can help detect cancer in its earliest stages, with an initial focus on breast cancer. (Mon, 17 Jul 2006 15:11:08 GMT)
DNAPrint Genomics Selects PT-502 Lead Research Compound for Development of Drug for Treating Depression
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced it has confirmed positive results in an animal model foranti-depressant activity for its PT-502 lead compound being developed withthe Massachusetts College of Pharmacy and Health Sciences. (Mon, 17 Jul 2006 15:11:49 GMT)
BioMachines Announces New Proteomics Services Division
Research Triangle Park, NC - BioMachines Inc., a privately-owned, RTP-based biotech company has announced a new services division - Applied Proteomics Services. (Mon, 17 Jul 2006 15:58:00 GMT)
Beckman Coulter licenses technology from Roche, finds no accounting irregularities
Beckman Coulter Inc. has licensed molecular technology from Roche Diagnostics, a unit of Swiss drug maker Roche Holding AG, and the company's audit committee found no accounting irregularities when reviewing claims by a former employee about accounting issues, the company said Monday. (Mon, 17 Jul 2006 16:05:56 GMT)
Scientists Isolate Leukemia Stem Cells In A Model Of Human Leukemia
Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston and their colleagues have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease. The leukemia stem cells isolated proved to be surprisingly different from normal blood stem cells -- a finding that may be good news for developing a drug that selectively targets them. (Mon, 17 Jul 2006 16:06:33 GMT)
Study identifies new role for breast cancer susceptibility gene
A recently discovered facet of the breast cancer susceptibility gene BRCA1 reveals a mechanism linking mutation of BRCA1 to formation of large blood vessels needed to support cancer progression. The findings demonstrate that, in addition to an impaired DNA damage response associated with cancer initiation, mutation of BRCA1 is also linked to manipulation of the tumor microenvironment. The (Mon, 17 Jul 2006 16:09:20 GMT)
Celera Makes Discovery in Alzheimer's Disease
In a discovery which could lead to future treatments, researchers at Celera Genomics have found that variants in the DAPK1 gene correlate strongly with risk for late-onset Alzheimer's disease. (Mon, 17 Jul 2006 18:09:16 GMT)
QuantRx(R) Biomedical Corporation Selects Synova Healthcare as the Exclusive Distributor of Its PAD Technology -- to Be
QuantRx® Biomedical Corporation (OTCBB: QTXB)announced today that it has entered into an exclusive distributionagreement for its PAD technology with Synova Healthcare, a distributor ofdiagnostic products. Under this agreement, QuantRx® received an up-frontpayment of $500,000 and is eligible to receive royalties, based upon sales,estimated to be worth multi-million dollars, over the term of (Mon, 17 Jul 2006 18:12:25 GMT)
Scientists Isolate Leukemia Stem Cells in Mouse Model
Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease. The leukemia stem cells isolated proved to be surprisingly different from normal blood stem cells -- a finding that may be good news for developing a drug that selectively targets them. (Mon, 17 Jul 2006 20:30:04 GMT)
New Strategy Rapidly Identifies Cancer Targets
In a step toward personalized medicine, Howard Hughes Medical Institute investigator Brian J. Druker and colleagues have developed a new technique to identify previously unknown genetic mutations that can trigger cancerous growth. By analyzing the proteins -- instead of the genes -- inside acute myeloid leukemia (AML) cells, the researchers have dramatically reduced the time it takes to zero in (Mon, 17 Jul 2006 22:06:14 GMT)
Rosetta Biosoftware licenses the Rosetta Resolver expression data analysis system to University of Nebraska-Lincoln
Rosetta Biosoftware announced today that University of Nebraska-Lincoln (UNL) licensed the Rosetta Resolver® system to study gene regulation networks at the UNL Center for Biotechnology. (Mon, 17 Jul 2006 22:15:34 GMT)
Animal Model Gives Stanford Scientists Insights Into Possible Therapies for Lymphedema
STANFORD, Calif.----July 17, 2006--For the millions of cancer survivors in the United States, emerging from surgery cancer-free is the ultimate victory. But many patients who clear the hurdle of cancer trauma will subsequently face a lifetime of swelling and discomfort, caused by an untreatable buildup of fluid in their tissues. (Tue, 18 Jul 2006 00:00:00 GMT)
Scientists with super powers
Two years ago, Professor Ah Chung Tsoi recognised the brilliance and passion of colleague Professor David Abramson. He took him aside after a meeting at the Australian Research Council, and a national e-research strategy was born. (Tue, 18 Jul 2006 01:16:55 GMT)
Promising preclinical study for DNAPrint candidate
DNAPrint Genomics PT-502, which is being developed with the Massachusetts College of Pharmacy and Health Sciences, has achieved positive results in an animal model for anti-depressant activity. (Tue, 18 Jul 2006 01:22:33 GMT)
Celera makes discovery in Alzheimer's disease
In a discovery which could lead to future treatments, researchers at Celera Genomics have found that variants in the DAPK1 gene correlate strongly with risk for late-onset Alzheimers disease. (Tue, 18 Jul 2006 01:22:43 GMT)
The Quest for the $1,000 Human Genome
DNA sequencing at birth, or at a routine doctor's visit, may be coming closer to becoming reality. (Tue, 18 Jul 2006 01:35:42 GMT)
Dabur's OncQuest plans expansion of cancer diagnostic business
OncQuest, a Dabur group company that has introduced an exclusive molecular testing facility in the area of diagnostic oncology for the first time in South East Asia, is eying at expanding its reach toward neighbouring countries in the coming months. (Tue, 18 Jul 2006 02:45:52 GMT)
Animal Model Gives Stanford Scientists Insights Into Possible Therapies for Lymphedema
For the millions of cancer survivors in the United States, emerging from surgery cancer-free is the ultimate victory. But many patients who clear the hurdle of cancer trauma will subsequently face a lifetime of swelling and discomfort, caused by an untreatable buildup of fluid in their tissues. (Tue, 18 Jul 2006 03:10:36 GMT)
Invitrogen, HUPO enter into proteomic research collaboration
Invitrogen Corporation and the Human Proteome Organisation (HUPO) have entered a scientific collaboration focused on advancing proteomic research through education initiatives, standardization of research protocols and development of advanced proteomic products. (Tue, 18 Jul 2006 03:45:35 GMT)
Molecular DNA Switch Found To Be The Same For All Life
Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California at Berkeley have shown that the core machinery for initiating DNA replication is the same for all three domains of life -- Archaea, Bacteria and Eukarya. (Tue, 18 Jul 2006 04:06:24 GMT)
Rising Need for Purity Spurs Growth in the European Nucleic Acid Isolation Market
The significance of nucleic acid and its multiple applications in a large number of research fields has increased the demand for pure isolations in Europe. Since nucleic acid is the fundamental substance preceding all other procedures in drug research, its integrity can enhance or damage research quality' (Tue, 18 Jul 2006 07:00:00 GMT)
MU Arts and Science to benefit from reallocation of UM funds
Money would be used to pay for late additions to faculty. As University of Missouri System leaders consider how to reallocate $20 million, one beneficiary is MU’s College of Arts and Science. (Tue, 18 Jul 2006 07:18:11 GMT)
UMass to offer protein services
WORCESTER - A University of Massachusetts Medical School group has agreed to provide protein-analysis services for BioMachines Inc., a privately held North Carolina company that makes specialized laboratory equipment. (Tue, 18 Jul 2006 08:51:08 GMT)
New role discovered for breast cancer susceptibility gene BRCA1
A recently discovered facet of the breast cancer susceptibility gene BRCA1 reveals a mechanism linking mutation of BRCA1 to formation of large blood vessels needed to support cancer progression. (Tue, 18 Jul 2006 10:48:17 GMT)
Researchers isolate rare cancer stem cells that cause leukemia
Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston and their colleagues have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease. (Tue, 18 Jul 2006 10:48:29 GMT)
DNAPrint Genomics Enters Into Research Agreement With Harvard Affiliate Beth Israel Deaconess Medical Center
DNAPrint Genomics, Inc. today announced that it has entered into a Sponsored Research Agreement with the Harvard Medical School's Beth Israel Deaconess Medical Center for research on a new, more potent and longer-acting form of the anemia drug Erythropoietin. (Tue, 18 Jul 2006 11:00:00 GMT)
Rosetta Biosoftware Licenses The Rosetta Resolver Expression Data Analysis System To University Of Nebraska-Lincoln
Rosetta Biosoftware announced today that University of Nebraska-Lincoln (UNL) licensed the Rosetta Resolver system to study gene regulation networks at the UNL Center for Biotechnology (Tue, 18 Jul 2006 11:52:32 GMT)
Paleontologists Establish First Age Distribution Of Non-avian Dinosaur Population
Did non-avian dinosaurs show survival patterns akin to extant living dinosaurs, the birds, as did their crocodilian cousins? Or, did they mirror that of more distantly related dinosaurs that lived in a similar environment? A pile of bones from the North American tyrannosaur Albertosaurus sarcophagus may hold the answer. (Tue, 18 Jul 2006 12:06:29 GMT)
HistoRx Names John Tonkinson, Ph.D., Vice President, Business Development
NEW HAVEN, Conn.----July 18, 2006--HistoRx, Inc. announced today that John L. Tonkinson, Ph.D. has been appointed to Vice President, Business Development. HistoRx is developing and commercializing a new generation of companion diagnostics, which will initially be focused on breast cancer. (Tue, 18 Jul 2006 12:30:00 GMT)
Proteomic Revolution and Customized Drugs Market Drives Demand for Mass Spectrometers in the U.S.
With the incorporation of technological advances in hardware design and computational power, there has been dramatic improvements in the reliability and design of present-day mass spectrometers. (Tue, 18 Jul 2006 12:30:00 GMT)
Cohen Independent Research Group Initiates Coverage of Power3 Medical Products
HOUSTON----July 18, 2006--Power3 Medical Products, Inc. , a leading proteomics company that develops and commercializes early detection diagnostic tests for breast cancer and neurodegenerative diseases, announced today that the Cohen Independent Research Group has initiated coverage of its stock. (Tue, 18 Jul 2006 12:58:00 GMT)
DNAPrint signs deal with Harvard affiliate
DNAPrint Genomics has signed an agreement with Beth Israel Deaconess Medical Center for research on an advanced form of a drug to treat people with anemia. (Tue, 18 Jul 2006 13:57:26 GMT)
Bio-IT Briefs
July 18, 2006 | Celera Genomics announced the publication of data from its research studies showing that variants in the death-associated protein kinase 1 (DAPK1) gene on human chromosome 9 correlate strongly with risk for late-onset Alzheimer's disease. (Tue, 18 Jul 2006 14:00:33 GMT)
DiaGenic ASA Presents Breakthrough Data on Development of the First Early Blood Test for Alzheimer's Disease At ICAD
MADRID, Spain----July 18, 2006--DiaGenic ASA today announced that it has achieved important milestones in the development of a diagnostic test for Alzheimer's disease. New scientific data based on gene expression analysis confirms that the development of a simple blood-based test for diagnosing Alzheimer's Disease is a realistic possibility in the near future, thereby enabling earlier (Tue, 18 Jul 2006 14:15:00 GMT)
TRADE NEWS: New Agilent Microarrays Offer High-Resolution Genomic Coverage, Enable Multiple Experiments per Slide
PALO ALTO, Calif.----July 18, 2006--Agilent Technologies Inc. today announced the availability of its new SurePrint microarrays, which contain more than 240,000 features. These DNA microarrays are optimized for applications such as gene expression, array-based comparative genomic hybridization , array-based chromatin immunoprecipitation , methylation, splice-variant analysis and microRNA studies. (Tue, 18 Jul 2006 15:00:00 GMT)
DNAPrint Genomics Enters Into Research Agreement With Harvard Affiliate Beth Israel Deaconess Medical Center
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced that it has entered into a Sponsored Research Agreement with theHarvard Medical School's Beth Israel Deaconess Medical Center (BIDMC) forresearch on a new, more potent and longer-acting form of the anemia drugErythropoietin (EPO). (Tue, 18 Jul 2006 15:10:30 GMT)
Matritech to Report Second Quarter 2006 Financial Results on August 1, 2006
NEWTON, Mass.----July 18, 2006--Matritech, Inc. will hold a conference call on Tuesday, August 1, 2006 at 8:30 a.m. Eastern Time to discuss second quarter 2006 financial results and provide a company update. (Tue, 18 Jul 2006 15:38:00 GMT)
DNAPrint Genomics Enters Into Research Agreement With Harvard Affiliate Beth Israel Deaconess Medical Center
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that it has entered into a Sponsored Research Agreement with the Harvard Medical School's Beth Israel Deaconess Medical Center (BIDMC) for research on a new, more potent and longer-acting form of the anemia drug Erythropoietin (EPO). (Tue, 18 Jul 2006 16:24:05 GMT)
Ciphergen Reports Biomarkers of Alzheimer's Disease
FREMONT, Calif., July 18 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. announced today results of a multi-site study aimed at discovering and validating biomarkers for Alzheimer's disease. (Tue, 18 Jul 2006 16:24:17 GMT)
Brinks Hofer Gilson & Lione Opens Office in Salt Lake City; Adds Key Talent to Its Biotech/Pharma Group
Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., announces the opening of a Salt Lake City office, coinciding with the hiring of two former Holland & Hart IP attorneys, Christopher L. (Tue, 18 Jul 2006 19:23:00 GMT)
Illumina Reports Financial Results for Second Quarter 2006
SAN DIEGO----July 18, 2006--Illumina, Inc. announced today its financial results for the second quarter and six-month period ended July 2, 2006. (Tue, 18 Jul 2006 20:01:00 GMT)
Previous 1 2 3 4 Next
